AN ACT REQUIRING TRANSPARENCY FROM HEALTH CARE ENTITIES THAT RECEIVE PRESCRIPTION DRUG DISCOUNTS.

HB 6810 requires healthcare providers receiving prescription drug discounts under the federal 340B program to submit regular reports detailing how they use those savings to benefit patients. This applies specifically to entities that qualify for Medicaid reimbursement. The bill mandates these reports as a condition for maintaining Medicaid funding, with updates required periodically. The law aims to ensure transparency about how drug discount savings directly support patient care rather than other expenses.